ProShare Advisors’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-10,836
| Closed | -$47K | – | 1588 |
|
|
2016
Q2 | $47K | Sell |
10,836
-1,112
| -9% | -$4.82K | ﹤0.01% | 1554 |
|
|
2016
Q1 | $67K | Sell |
11,948
-1,238
| -9% | -$6.94K | ﹤0.01% | 1542 |
|
|
2015
Q4 | $227K | Buy |
13,186
+2,646
| +25% | +$45.6K | ﹤0.01% | 1468 |
|
|
2015
Q3 | $222K | Sell |
10,540
-757
| -7% | -$15.9K | ﹤0.01% | 1272 |
|
|
2015
Q2 | $559K | Sell |
11,297
-1,039
| -8% | -$51.4K | 0.01% | 1055 |
|
|
2015
Q1 | $966K | Buy |
12,336
+1,548
| +14% | +$121K | 0.01% | 861 |
|
|
2014
Q4 | $654K | Sell |
10,788
-394
| -4% | -$23.9K | 0.01% | 1079 |
|
|
2014
Q3 | $476K | Sell |
11,182
-1,549
| -12% | -$65.9K | 0.01% | 1448 |
|
|
2014
Q2 | $787K | Sell |
12,731
-5,292
| -29% | -$327K | 0.01% | 1290 |
|
|
2014
Q1 | $1.17M | Buy |
18,023
+12,818
| +246% | +$834K | 0.01% | 1171 |
|
|
2013
Q4 | $293K | Sell |
5,205
-4,250
| -45% | -$239K | ﹤0.01% | 1167 |
|
|
2013
Q3 | $581K | Buy |
9,455
+2,286
| +32% | +$140K | 0.01% | 1335 |
|
|
2013
Q2 | $419K | Buy |
+7,169
| New | +$419K | 0.01% | 1466 |
|